Ocera Therapeutics is Drug Discovery in United States that focus on chronic liver business. Founded in 1998. They cover business area such as developer, novel therapeutic, acute and chronic liver disease, an ammonia scavenger, (IV, oral formulation, hyperammonemia, STOP-HE, physician, biopharmaceutical, neurocognitive symptom, acute HE.
1998
( 26 years old in 2024 )
Chronic Liver
-
555 Twin Dolphin Drive
Suite 615
Redwood City, CA 94065
United States
Private
developernovel therapeuticacute and chronic liver diseasean ammonia scavenger(IVoral formulationhyperammonemiaSTOP-HEphysicianbiopharmaceuticalneurocognitive symptomacute HE
* We use standard office opening hours in near Ocera Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ocera Therapeutics is Drug Discovery business from United States that founded in 1998 (26 years old in 2024), Ocera Therapeutics business is focusing on Chronic Liver.
Ocera Therapeutics headquarter office and corporate office address is located in 555 Twin Dolphin Drive Suite 615 Redwood City, CA 94065 United States.
Ocera Therapeutics was founded in United States.
In 2024, Ocera Therapeutics is currently focus on chronic liver sector.
Above is snippet of Google Trends for "chronic liver" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ocera Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
